nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP2E1—obesity	0.176	1	CbGaD
Dexmedetomidine—SLC6A2—Diethylpropion—obesity	0.0586	0.0957	CbGbCtD
Dexmedetomidine—ADRA1B—Phendimetrazine—obesity	0.0487	0.0794	CbGbCtD
Dexmedetomidine—SLC6A2—Phendimetrazine—obesity	0.0444	0.0725	CbGbCtD
Dexmedetomidine—SLC6A2—Sibutramine—obesity	0.0444	0.0725	CbGbCtD
Dexmedetomidine—ADRA2C—Methamphetamine—obesity	0.0368	0.06	CbGbCtD
Dexmedetomidine—ADRA2B—Methamphetamine—obesity	0.0349	0.0569	CbGbCtD
Dexmedetomidine—SLC6A2—Benzphetamine—obesity	0.0337	0.055	CbGbCtD
Dexmedetomidine—SLC6A2—Phentermine—obesity	0.0337	0.055	CbGbCtD
Dexmedetomidine—SLC6A2—Phenylpropanolamine—obesity	0.0321	0.0524	CbGbCtD
Dexmedetomidine—ADRA2A—Benzphetamine—obesity	0.0304	0.0495	CbGbCtD
Dexmedetomidine—ADRA2A—Phenylpropanolamine—obesity	0.029	0.0473	CbGbCtD
Dexmedetomidine—SLC6A2—Bupropion—obesity	0.0286	0.0467	CbGbCtD
Dexmedetomidine—SLC6A2—Methamphetamine—obesity	0.0269	0.0439	CbGbCtD
Dexmedetomidine—ADRA2A—Methamphetamine—obesity	0.0243	0.0396	CbGbCtD
Dexmedetomidine—CYP2E1—Bupropion—obesity	0.018	0.0294	CbGbCtD
Dexmedetomidine—CYP2E1—Cimetidine—obesity	0.0132	0.0216	CbGbCtD
Dexmedetomidine—CYP1A2—Phentermine—obesity	0.0123	0.02	CbGbCtD
Dexmedetomidine—CYP1A2—Phenylpropanolamine—obesity	0.0117	0.0191	CbGbCtD
Dexmedetomidine—CYP1A2—Bupropion—obesity	0.0104	0.017	CbGbCtD
Dexmedetomidine—CYP2D6—Phentermine—obesity	0.0101	0.0165	CbGbCtD
Dexmedetomidine—CYP2D6—Bupropion—obesity	0.00859	0.014	CbGbCtD
Dexmedetomidine—CYP2D6—Methamphetamine—obesity	0.00807	0.0132	CbGbCtD
Dexmedetomidine—CYP1A2—Cimetidine—obesity	0.00765	0.0125	CbGbCtD
Dexmedetomidine—CYP2D6—Cimetidine—obesity	0.0063	0.0103	CbGbCtD
Dexmedetomidine—SLC6A2—sympathetic nervous system—obesity	0.0022	0.213	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—obesity	0.00148	0.143	CbGeAlD
Dexmedetomidine—SLC6A2—respiratory system—obesity	0.00038	0.0368	CbGeAlD
Dexmedetomidine—Diarrhoea—Benzphetamine—obesity	0.00036	0.00353	CcSEcCtD
Dexmedetomidine—Anxiety—Diethylpropion—obesity	0.000354	0.00348	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Bupropion—obesity	0.000352	0.00345	CcSEcCtD
Dexmedetomidine—Constipation—Phenylpropanolamine—obesity	0.00035	0.00344	CcSEcCtD
Dexmedetomidine—Dizziness—Benzphetamine—obesity	0.000348	0.00341	CcSEcCtD
Dexmedetomidine—Dry mouth—Diethylpropion—obesity	0.000348	0.00341	CcSEcCtD
Dexmedetomidine—Headache—Methamphetamine—obesity	0.000341	0.00335	CcSEcCtD
Dexmedetomidine—CYP2D6—hindbrain—obesity	0.000341	0.033	CbGeAlD
Dexmedetomidine—Gastrointestinal disorder—Phentermine—obesity	0.000338	0.00332	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Phenylpropanolamine—obesity	0.000337	0.00331	CcSEcCtD
Dexmedetomidine—Anxiety—Cimetidine—obesity	0.000337	0.00331	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Sibutramine—obesity	0.000335	0.00329	CcSEcCtD
Dexmedetomidine—Constipation—Phentermine—obesity	0.000335	0.00329	CcSEcCtD
Dexmedetomidine—Tachycardia—Diethylpropion—obesity	0.000332	0.00326	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Orlistat—obesity	0.000331	0.00325	CcSEcCtD
Dexmedetomidine—Rigors—Topiramate—obesity	0.00033	0.00324	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Diethylpropion—obesity	0.000329	0.00323	CcSEcCtD
Dexmedetomidine—Headache—Benzphetamine—obesity	0.000329	0.00323	CcSEcCtD
Dexmedetomidine—Diarrhoea—Phendimetrazine—obesity	0.000328	0.00322	CcSEcCtD
Dexmedetomidine—Gamma-glutamyltransferase increased—Topiramate—obesity	0.000328	0.00322	CcSEcCtD
Dexmedetomidine—Confusional state—Cimetidine—obesity	0.000327	0.00321	CcSEcCtD
Dexmedetomidine—ADRA1D—endocrine gland—obesity	0.000324	0.0313	CbGeAlD
Dexmedetomidine—Thirst—Bupropion—obesity	0.000323	0.00317	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Sibutramine—obesity	0.000321	0.00315	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Cimetidine—obesity	0.000317	0.00312	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Sibutramine—obesity	0.000317	0.00312	CcSEcCtD
Dexmedetomidine—Abdominal distension—Orlistat—obesity	0.000317	0.00311	CcSEcCtD
Dexmedetomidine—Dizziness—Phendimetrazine—obesity	0.000317	0.00311	CcSEcCtD
Dexmedetomidine—Tachycardia—Cimetidine—obesity	0.000316	0.00311	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Bupropion—obesity	0.000315	0.00309	CcSEcCtD
Dexmedetomidine—Speech disorder—Topiramate—obesity	0.000313	0.00308	CcSEcCtD
Dexmedetomidine—Delirium—Topiramate—obesity	0.000313	0.00308	CcSEcCtD
Dexmedetomidine—Nausea—Benzphetamine—obesity	0.000312	0.00307	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Sibutramine—obesity	0.000311	0.00305	CcSEcCtD
Dexmedetomidine—Abdominal pain—Phentermine—obesity	0.00031	0.00304	CcSEcCtD
Dexmedetomidine—Bronchospasm—Orlistat—obesity	0.00031	0.00304	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Topiramate—obesity	0.000307	0.00301	CcSEcCtD
Dexmedetomidine—Abdominal distension—Sibutramine—obesity	0.000307	0.00301	CcSEcCtD
Dexmedetomidine—Sweating increased—Orlistat—obesity	0.000307	0.00301	CcSEcCtD
Dexmedetomidine—Dyspnoea—Diethylpropion—obesity	0.000304	0.00298	CcSEcCtD
Dexmedetomidine—Somnolence—Diethylpropion—obesity	0.000303	0.00297	CcSEcCtD
Dexmedetomidine—Headache—Phendimetrazine—obesity	0.0003	0.00295	CcSEcCtD
Dexmedetomidine—Hypocalcaemia—Topiramate—obesity	0.000295	0.00289	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Diethylpropion—obesity	0.000294	0.00289	CcSEcCtD
Dexmedetomidine—Oliguria—Topiramate—obesity	0.000293	0.00287	CcSEcCtD
Dexmedetomidine—CYP1A2—respiratory system—obesity	0.000292	0.0283	CbGeAlD
Dexmedetomidine—Constipation—Diethylpropion—obesity	0.000291	0.00286	CcSEcCtD
Dexmedetomidine—CYP1A1—respiratory system—obesity	0.000289	0.0279	CbGeAlD
Dexmedetomidine—Somnolence—Cimetidine—obesity	0.000288	0.00283	CcSEcCtD
Dexmedetomidine—ADRA2A—islet of Langerhans—obesity	0.000285	0.0276	CbGeAlD
Dexmedetomidine—Nausea—Phendimetrazine—obesity	0.000285	0.00279	CcSEcCtD
Dexmedetomidine—ADRA2C—adrenal cortex—obesity	0.000283	0.0274	CbGeAlD
Dexmedetomidine—Feeling abnormal—Diethylpropion—obesity	0.000281	0.00276	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Topiramate—obesity	0.000278	0.00273	CcSEcCtD
Dexmedetomidine—Constipation—Cimetidine—obesity	0.000277	0.00272	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Orlistat—obesity	0.000275	0.0027	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Sibutramine—obesity	0.000275	0.0027	CcSEcCtD
Dexmedetomidine—Pneumonia—Sibutramine—obesity	0.000273	0.00268	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Orlistat—obesity	0.000273	0.00268	CcSEcCtD
Dexmedetomidine—Dizziness—Phenylpropanolamine—obesity	0.000271	0.00266	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Topiramate—obesity	0.00027	0.00265	CcSEcCtD
Dexmedetomidine—Diarrhoea—Phentermine—obesity	0.000268	0.00263	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Sibutramine—obesity	0.000268	0.00263	CcSEcCtD
Dexmedetomidine—Abdominal distension—Bupropion—obesity	0.000267	0.00262	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Cimetidine—obesity	0.000267	0.00262	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Sibutramine—obesity	0.000266	0.00261	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Sibutramine—obesity	0.000266	0.00261	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Sibutramine—obesity	0.000264	0.00259	CcSEcCtD
Dexmedetomidine—CYP2E1—respiratory system—obesity	0.000263	0.0255	CbGeAlD
Dexmedetomidine—Bronchospasm—Bupropion—obesity	0.000261	0.00256	CcSEcCtD
Dexmedetomidine—Vomiting—Phenylpropanolamine—obesity	0.00026	0.00255	CcSEcCtD
Dexmedetomidine—Dizziness—Phentermine—obesity	0.000259	0.00254	CcSEcCtD
Dexmedetomidine—Sweating increased—Bupropion—obesity	0.000259	0.00254	CcSEcCtD
Dexmedetomidine—Rash—Phenylpropanolamine—obesity	0.000258	0.00253	CcSEcCtD
Dexmedetomidine—Dermatitis—Phenylpropanolamine—obesity	0.000258	0.00253	CcSEcCtD
Dexmedetomidine—Body temperature increased—Cimetidine—obesity	0.000256	0.00252	CcSEcCtD
Dexmedetomidine—Fluid retention—Topiramate—obesity	0.000256	0.00251	CcSEcCtD
Dexmedetomidine—Haemoglobin—Orlistat—obesity	0.000253	0.00249	CcSEcCtD
Dexmedetomidine—Haemorrhage—Orlistat—obesity	0.000252	0.00247	CcSEcCtD
Dexmedetomidine—Vomiting—Phentermine—obesity	0.000249	0.00244	CcSEcCtD
Dexmedetomidine—Bradycardia—Sibutramine—obesity	0.000248	0.00244	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Orlistat—obesity	0.000248	0.00244	CcSEcCtD
Dexmedetomidine—Rash—Phentermine—obesity	0.000247	0.00242	CcSEcCtD
Dexmedetomidine—Dermatitis—Phentermine—obesity	0.000247	0.00242	CcSEcCtD
Dexmedetomidine—Headache—Phentermine—obesity	0.000245	0.00241	CcSEcCtD
Dexmedetomidine—Haemoglobin—Sibutramine—obesity	0.000245	0.00241	CcSEcCtD
Dexmedetomidine—Haemorrhage—Sibutramine—obesity	0.000244	0.00239	CcSEcCtD
Dexmedetomidine—Nausea—Phenylpropanolamine—obesity	0.000243	0.00239	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Sibutramine—obesity	0.00024	0.00236	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Bupropion—obesity	0.00024	0.00235	CcSEcCtD
Dexmedetomidine—Pneumonia—Bupropion—obesity	0.000238	0.00234	CcSEcCtD
Dexmedetomidine—Abnormal vision—Topiramate—obesity	0.000235	0.00231	CcSEcCtD
Dexmedetomidine—Visual impairment—Sibutramine—obesity	0.000235	0.00231	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Bupropion—obesity	0.000233	0.00229	CcSEcCtD
Dexmedetomidine—Diarrhoea—Diethylpropion—obesity	0.000233	0.00229	CcSEcCtD
Dexmedetomidine—Nausea—Phentermine—obesity	0.000233	0.00228	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Bupropion—obesity	0.000232	0.00228	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Bupropion—obesity	0.000232	0.00228	CcSEcCtD
Dexmedetomidine—SLC6A2—adrenal gland—obesity	0.000231	0.0223	CbGeAlD
Dexmedetomidine—Urinary tract infection—Bupropion—obesity	0.00023	0.00226	CcSEcCtD
Dexmedetomidine—ADRA2C—pituitary gland—obesity	0.000229	0.0221	CbGeAlD
Dexmedetomidine—ADRA2C—adipose tissue—obesity	0.000228	0.022	CbGeAlD
Dexmedetomidine—Mediastinal disorder—Orlistat—obesity	0.000227	0.00223	CcSEcCtD
Dexmedetomidine—Dizziness—Diethylpropion—obesity	0.000225	0.00221	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Topiramate—obesity	0.000225	0.00221	CcSEcCtD
Dexmedetomidine—Diarrhoea—Cimetidine—obesity	0.000222	0.00218	CcSEcCtD
Dexmedetomidine—Angiopathy—Sibutramine—obesity	0.000221	0.00217	CcSEcCtD
Dexmedetomidine—Mental disorder—Orlistat—obesity	0.000221	0.00217	CcSEcCtD
Dexmedetomidine—Malnutrition—Orlistat—obesity	0.000219	0.00215	CcSEcCtD
Dexmedetomidine—Chills—Sibutramine—obesity	0.000219	0.00215	CcSEcCtD
Dexmedetomidine—Arrhythmia—Sibutramine—obesity	0.000218	0.00214	CcSEcCtD
Dexmedetomidine—Vomiting—Diethylpropion—obesity	0.000217	0.00213	CcSEcCtD
Dexmedetomidine—Rash—Diethylpropion—obesity	0.000215	0.00211	CcSEcCtD
Dexmedetomidine—Dermatitis—Diethylpropion—obesity	0.000215	0.00211	CcSEcCtD
Dexmedetomidine—Dizziness—Cimetidine—obesity	0.000214	0.0021	CcSEcCtD
Dexmedetomidine—Haemoglobin—Bupropion—obesity	0.000214	0.0021	CcSEcCtD
Dexmedetomidine—Headache—Diethylpropion—obesity	0.000213	0.0021	CcSEcCtD
Dexmedetomidine—Haemorrhage—Bupropion—obesity	0.000213	0.00209	CcSEcCtD
Dexmedetomidine—Malnutrition—Sibutramine—obesity	0.000212	0.00208	CcSEcCtD
Dexmedetomidine—Hallucination—Bupropion—obesity	0.000211	0.00208	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Bupropion—obesity	0.000209	0.00206	CcSEcCtD
Dexmedetomidine—Vomiting—Cimetidine—obesity	0.000206	0.00202	CcSEcCtD
Dexmedetomidine—Thirst—Topiramate—obesity	0.000206	0.00202	CcSEcCtD
Dexmedetomidine—Visual impairment—Bupropion—obesity	0.000205	0.00201	CcSEcCtD
Dexmedetomidine—Rash—Cimetidine—obesity	0.000204	0.00201	CcSEcCtD
Dexmedetomidine—ADRA2C—adrenal gland—obesity	0.000204	0.0198	CbGeAlD
Dexmedetomidine—Dermatitis—Cimetidine—obesity	0.000204	0.002	CcSEcCtD
Dexmedetomidine—Headache—Cimetidine—obesity	0.000203	0.00199	CcSEcCtD
Dexmedetomidine—Nausea—Diethylpropion—obesity	0.000202	0.00199	CcSEcCtD
Dexmedetomidine—CYP2E1—cardiovascular system—obesity	0.000202	0.0195	CbGeAlD
Dexmedetomidine—Hypoglycaemia—Topiramate—obesity	0.000201	0.00197	CcSEcCtD
Dexmedetomidine—SLC6A2—endocrine gland—obesity	0.0002	0.0194	CbGeAlD
Dexmedetomidine—Cardiac disorder—Bupropion—obesity	0.000197	0.00194	CcSEcCtD
Dexmedetomidine—Anaemia—Sibutramine—obesity	0.000196	0.00193	CcSEcCtD
Dexmedetomidine—Agitation—Sibutramine—obesity	0.000195	0.00191	CcSEcCtD
Dexmedetomidine—CYP1A1—adipose tissue—obesity	0.000195	0.0189	CbGeAlD
Dexmedetomidine—Angiopathy—Bupropion—obesity	0.000193	0.00189	CcSEcCtD
Dexmedetomidine—Nausea—Cimetidine—obesity	0.000193	0.00189	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Bupropion—obesity	0.000192	0.00188	CcSEcCtD
Dexmedetomidine—Chills—Bupropion—obesity	0.000191	0.00187	CcSEcCtD
Dexmedetomidine—Convulsion—Orlistat—obesity	0.00019	0.00187	CcSEcCtD
Dexmedetomidine—Arrhythmia—Bupropion—obesity	0.00019	0.00186	CcSEcCtD
Dexmedetomidine—Mental disorder—Bupropion—obesity	0.000186	0.00183	CcSEcCtD
Dexmedetomidine—Anxiety—Orlistat—obesity	0.000186	0.00183	CcSEcCtD
Dexmedetomidine—CYP1A2—digestive system—obesity	0.000186	0.018	CbGeAlD
Dexmedetomidine—Malnutrition—Bupropion—obesity	0.000185	0.00182	CcSEcCtD
Dexmedetomidine—Convulsion—Sibutramine—obesity	0.000184	0.00181	CcSEcCtD
Dexmedetomidine—CYP1A1—digestive system—obesity	0.000183	0.0178	CbGeAlD
Dexmedetomidine—Hypertension—Sibutramine—obesity	0.000183	0.0018	CcSEcCtD
Dexmedetomidine—Dry mouth—Orlistat—obesity	0.000183	0.00179	CcSEcCtD
Dexmedetomidine—ADRA2A—pituitary gland—obesity	0.000182	0.0177	CbGeAlD
Dexmedetomidine—ADRA2A—adipose tissue—obesity	0.000182	0.0176	CbGeAlD
Dexmedetomidine—Anxiety—Sibutramine—obesity	0.00018	0.00177	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Topiramate—obesity	0.000178	0.00175	CcSEcCtD
Dexmedetomidine—Infection—Orlistat—obesity	0.000178	0.00175	CcSEcCtD
Dexmedetomidine—Dry mouth—Sibutramine—obesity	0.000177	0.00173	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Topiramate—obesity	0.000176	0.00173	CcSEcCtD
Dexmedetomidine—Confusional state—Sibutramine—obesity	0.000175	0.00171	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Orlistat—obesity	0.000173	0.0017	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Topiramate—obesity	0.000173	0.00169	CcSEcCtD
Dexmedetomidine—Infection—Sibutramine—obesity	0.000172	0.00169	CcSEcCtD
Dexmedetomidine—Anaemia—Bupropion—obesity	0.000171	0.00168	CcSEcCtD
Dexmedetomidine—Abdominal distension—Topiramate—obesity	0.00017	0.00167	CcSEcCtD
Dexmedetomidine—Agitation—Bupropion—obesity	0.00017	0.00167	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Sibutramine—obesity	0.00017	0.00167	CcSEcCtD
Dexmedetomidine—Tachycardia—Sibutramine—obesity	0.000169	0.00166	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Sibutramine—obesity	0.000167	0.00164	CcSEcCtD
Dexmedetomidine—CYP2E1—digestive system—obesity	0.000167	0.0162	CbGeAlD
Dexmedetomidine—Sweating increased—Topiramate—obesity	0.000165	0.00162	CcSEcCtD
Dexmedetomidine—ADRA2A—adrenal gland—obesity	0.000163	0.0158	CbGeAlD
Dexmedetomidine—Hypotension—Sibutramine—obesity	0.000162	0.00159	CcSEcCtD
Dexmedetomidine—Convulsion—Bupropion—obesity	0.00016	0.00157	CcSEcCtD
Dexmedetomidine—Hypertension—Bupropion—obesity	0.00016	0.00157	CcSEcCtD
Dexmedetomidine—ADRA2C—liver—obesity	0.00016	0.0155	CbGeAlD
Dexmedetomidine—CYP2E1—adrenal gland—obesity	0.000159	0.0154	CbGeAlD
Dexmedetomidine—Anxiety—Bupropion—obesity	0.000157	0.00154	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Orlistat—obesity	0.000155	0.00152	CcSEcCtD
Dexmedetomidine—Dyspnoea—Sibutramine—obesity	0.000154	0.00152	CcSEcCtD
Dexmedetomidine—Dry mouth—Bupropion—obesity	0.000154	0.00151	CcSEcCtD
Dexmedetomidine—Somnolence—Sibutramine—obesity	0.000154	0.00151	CcSEcCtD
Dexmedetomidine—CYP1A2—endocrine gland—obesity	0.000154	0.0149	CbGeAlD
Dexmedetomidine—Pain—Orlistat—obesity	0.000153	0.0015	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Topiramate—obesity	0.000153	0.0015	CcSEcCtD
Dexmedetomidine—Confusional state—Bupropion—obesity	0.000152	0.00149	CcSEcCtD
Dexmedetomidine—Pneumonia—Topiramate—obesity	0.000152	0.00149	CcSEcCtD
Dexmedetomidine—CYP1A1—endocrine gland—obesity	0.000152	0.0147	CbGeAlD
Dexmedetomidine—Infection—Bupropion—obesity	0.00015	0.00147	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Sibutramine—obesity	0.00015	0.00147	CcSEcCtD
Dexmedetomidine—Constipation—Sibutramine—obesity	0.000148	0.00145	CcSEcCtD
Dexmedetomidine—Pain—Sibutramine—obesity	0.000148	0.00145	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Topiramate—obesity	0.000148	0.00145	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Bupropion—obesity	0.000148	0.00145	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Orlistat—obesity	0.000147	0.00145	CcSEcCtD
Dexmedetomidine—Tachycardia—Bupropion—obesity	0.000147	0.00145	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Topiramate—obesity	0.000147	0.00144	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Orlistat—obesity	0.000146	0.00144	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Bupropion—obesity	0.000146	0.00143	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Sibutramine—obesity	0.000143	0.0014	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Sibutramine—obesity	0.000142	0.00139	CcSEcCtD
Dexmedetomidine—Body temperature increased—Orlistat—obesity	0.000141	0.00139	CcSEcCtD
Dexmedetomidine—Abdominal pain—Orlistat—obesity	0.000141	0.00139	CcSEcCtD
Dexmedetomidine—ADRA2A—endocrine gland—obesity	0.000141	0.0137	CbGeAlD
Dexmedetomidine—Hypotension—Bupropion—obesity	0.000141	0.00139	CcSEcCtD
Dexmedetomidine—CYP1A2—liver—obesity	0.000139	0.0134	CbGeAlD
Dexmedetomidine—CYP2E1—endocrine gland—obesity	0.000138	0.0134	CbGeAlD
Dexmedetomidine—Bradycardia—Topiramate—obesity	0.000138	0.00135	CcSEcCtD
Dexmedetomidine—Abdominal pain—Sibutramine—obesity	0.000137	0.00134	CcSEcCtD
Dexmedetomidine—Body temperature increased—Sibutramine—obesity	0.000137	0.00134	CcSEcCtD
Dexmedetomidine—CYP1A1—liver—obesity	0.000137	0.0132	CbGeAlD
Dexmedetomidine—Haemoglobin—Topiramate—obesity	0.000136	0.00134	CcSEcCtD
Dexmedetomidine—Haemorrhage—Topiramate—obesity	0.000135	0.00133	CcSEcCtD
Dexmedetomidine—Hallucination—Topiramate—obesity	0.000135	0.00132	CcSEcCtD
Dexmedetomidine—Dyspnoea—Bupropion—obesity	0.000135	0.00132	CcSEcCtD
Dexmedetomidine—Somnolence—Bupropion—obesity	0.000134	0.00132	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Topiramate—obesity	0.000133	0.00131	CcSEcCtD
Dexmedetomidine—CYP2D6—digestive system—obesity	0.000132	0.0128	CbGeAlD
Dexmedetomidine—Visual impairment—Topiramate—obesity	0.00013	0.00128	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Bupropion—obesity	0.00013	0.00128	CcSEcCtD
Dexmedetomidine—Pain—Bupropion—obesity	0.000129	0.00127	CcSEcCtD
Dexmedetomidine—Constipation—Bupropion—obesity	0.000129	0.00127	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Topiramate—obesity	0.000126	0.00123	CcSEcCtD
Dexmedetomidine—CYP2E1—liver—obesity	0.000125	0.0121	CbGeAlD
Dexmedetomidine—Feeling abnormal—Bupropion—obesity	0.000124	0.00122	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Bupropion—obesity	0.000123	0.00121	CcSEcCtD
Dexmedetomidine—Angiopathy—Topiramate—obesity	0.000123	0.00121	CcSEcCtD
Dexmedetomidine—Diarrhoea—Orlistat—obesity	0.000122	0.0012	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Topiramate—obesity	0.000122	0.0012	CcSEcCtD
Dexmedetomidine—Chills—Topiramate—obesity	0.000121	0.00119	CcSEcCtD
Dexmedetomidine—Abdominal pain—Bupropion—obesity	0.000119	0.00117	CcSEcCtD
Dexmedetomidine—Body temperature increased—Bupropion—obesity	0.000119	0.00117	CcSEcCtD
Dexmedetomidine—Mental disorder—Topiramate—obesity	0.000119	0.00116	CcSEcCtD
Dexmedetomidine—Diarrhoea—Sibutramine—obesity	0.000119	0.00116	CcSEcCtD
Dexmedetomidine—Dizziness—Orlistat—obesity	0.000118	0.00116	CcSEcCtD
Dexmedetomidine—Malnutrition—Topiramate—obesity	0.000118	0.00116	CcSEcCtD
Dexmedetomidine—Dizziness—Sibutramine—obesity	0.000115	0.00112	CcSEcCtD
Dexmedetomidine—Vomiting—Orlistat—obesity	0.000114	0.00112	CcSEcCtD
Dexmedetomidine—Rash—Orlistat—obesity	0.000113	0.00111	CcSEcCtD
Dexmedetomidine—Dermatitis—Orlistat—obesity	0.000113	0.00111	CcSEcCtD
Dexmedetomidine—Headache—Orlistat—obesity	0.000112	0.0011	CcSEcCtD
Dexmedetomidine—Vomiting—Sibutramine—obesity	0.00011	0.00108	CcSEcCtD
Dexmedetomidine—CYP2D6—endocrine gland—obesity	0.000109	0.0106	CbGeAlD
Dexmedetomidine—Rash—Sibutramine—obesity	0.000109	0.00107	CcSEcCtD
Dexmedetomidine—Dermatitis—Sibutramine—obesity	0.000109	0.00107	CcSEcCtD
Dexmedetomidine—Anaemia—Topiramate—obesity	0.000109	0.00107	CcSEcCtD
Dexmedetomidine—Headache—Sibutramine—obesity	0.000109	0.00107	CcSEcCtD
Dexmedetomidine—Agitation—Topiramate—obesity	0.000108	0.00106	CcSEcCtD
Dexmedetomidine—Nausea—Orlistat—obesity	0.000106	0.00104	CcSEcCtD
Dexmedetomidine—Diarrhoea—Bupropion—obesity	0.000103	0.00101	CcSEcCtD
Dexmedetomidine—Nausea—Sibutramine—obesity	0.000103	0.00101	CcSEcCtD
Dexmedetomidine—Convulsion—Topiramate—obesity	0.000102	0.001	CcSEcCtD
Dexmedetomidine—Hypertension—Topiramate—obesity	0.000102	0.000999	CcSEcCtD
Dexmedetomidine—Anxiety—Topiramate—obesity	0.0001	0.000982	CcSEcCtD
Dexmedetomidine—Dizziness—Bupropion—obesity	9.98e-05	0.00098	CcSEcCtD
Dexmedetomidine—CYP2D6—liver—obesity	9.87e-05	0.00955	CbGeAlD
Dexmedetomidine—Dry mouth—Topiramate—obesity	9.81e-05	0.000964	CcSEcCtD
Dexmedetomidine—Confusional state—Topiramate—obesity	9.7e-05	0.000952	CcSEcCtD
Dexmedetomidine—Vomiting—Bupropion—obesity	9.6e-05	0.000943	CcSEcCtD
Dexmedetomidine—Infection—Topiramate—obesity	9.56e-05	0.000938	CcSEcCtD
Dexmedetomidine—Rash—Bupropion—obesity	9.52e-05	0.000935	CcSEcCtD
Dexmedetomidine—Dermatitis—Bupropion—obesity	9.51e-05	0.000934	CcSEcCtD
Dexmedetomidine—Headache—Bupropion—obesity	9.46e-05	0.000929	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Topiramate—obesity	9.42e-05	0.000925	CcSEcCtD
Dexmedetomidine—Tachycardia—Topiramate—obesity	9.39e-05	0.000922	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Topiramate—obesity	9.3e-05	0.000913	CcSEcCtD
Dexmedetomidine—Hypotension—Topiramate—obesity	8.99e-05	0.000883	CcSEcCtD
Dexmedetomidine—Nausea—Bupropion—obesity	8.97e-05	0.000881	CcSEcCtD
Dexmedetomidine—Dyspnoea—Topiramate—obesity	8.58e-05	0.000842	CcSEcCtD
Dexmedetomidine—Somnolence—Topiramate—obesity	8.55e-05	0.00084	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Topiramate—obesity	8.3e-05	0.000815	CcSEcCtD
Dexmedetomidine—Pain—Topiramate—obesity	8.23e-05	0.000808	CcSEcCtD
Dexmedetomidine—Constipation—Topiramate—obesity	8.23e-05	0.000808	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Topiramate—obesity	7.93e-05	0.000778	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Topiramate—obesity	7.87e-05	0.000772	CcSEcCtD
Dexmedetomidine—Abdominal pain—Topiramate—obesity	7.6e-05	0.000747	CcSEcCtD
Dexmedetomidine—Body temperature increased—Topiramate—obesity	7.6e-05	0.000747	CcSEcCtD
Dexmedetomidine—Diarrhoea—Topiramate—obesity	6.58e-05	0.000646	CcSEcCtD
Dexmedetomidine—Dizziness—Topiramate—obesity	6.36e-05	0.000625	CcSEcCtD
Dexmedetomidine—Vomiting—Topiramate—obesity	6.12e-05	0.000601	CcSEcCtD
Dexmedetomidine—Rash—Topiramate—obesity	6.07e-05	0.000596	CcSEcCtD
Dexmedetomidine—Dermatitis—Topiramate—obesity	6.06e-05	0.000595	CcSEcCtD
Dexmedetomidine—Headache—Topiramate—obesity	6.03e-05	0.000592	CcSEcCtD
Dexmedetomidine—Nausea—Topiramate—obesity	5.71e-05	0.000561	CcSEcCtD
Dexmedetomidine—CYP1A2—Metabolism—BCHE—obesity	2.71e-06	2.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3R1—obesity	2.7e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOS3—obesity	2.7e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CG—obesity	2.7e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARA—obesity	2.69e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IGF1—obesity	2.69e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT2—obesity	2.69e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CAV1—obesity	2.68e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOA1—obesity	2.68e-06	2.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS1—obesity	2.67e-06	2.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CG—obesity	2.66e-06	2.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—obesity	2.65e-06	2.68e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—C3—obesity	2.65e-06	2.67e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2E1—obesity	2.61e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—obesity	2.61e-06	2.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AGT—obesity	2.61e-06	2.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—INS—obesity	2.6e-06	2.62e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NQO1—obesity	2.58e-06	2.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3CD—obesity	2.58e-06	2.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—PIK3CA—obesity	2.57e-06	2.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARG—obesity	2.57e-06	2.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—obesity	2.57e-06	2.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	2.56e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—COMT—obesity	2.56e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—obesity	2.55e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—INS—obesity	2.55e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—obesity	2.55e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SERPINE1—obesity	2.55e-06	2.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—obesity	2.53e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CAV1—obesity	2.53e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.53e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOA1—obesity	2.53e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS2—obesity	2.52e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—INS—obesity	2.52e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARGC1A—obesity	2.52e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GNB3—obesity	2.52e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGT—obesity	2.52e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—obesity	2.51e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3CB—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT2—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—AKT1—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.51e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MTOR—obesity	2.49e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3CB—obesity	2.49e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—obesity	2.49e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TYK2—obesity	2.48e-06	2.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GCG—obesity	2.48e-06	2.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SLC2A4—obesity	2.48e-06	2.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1—obesity	2.47e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT2—obesity	2.47e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LEP—obesity	2.47e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—obesity	2.47e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RHOA—obesity	2.46e-06	2.48e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GNAS—obesity	2.45e-06	2.48e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CG—obesity	2.45e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CAV1—obesity	2.44e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYCS—obesity	2.44e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOA1—obesity	2.44e-06	2.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3R1—obesity	2.44e-06	2.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOS3—obesity	2.44e-06	2.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.42e-06	2.44e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3CD—obesity	2.41e-06	2.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOB—obesity	2.4e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GGT1—obesity	2.4e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GOT1—obesity	2.4e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	2.39e-06	2.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SERPINE1—obesity	2.38e-06	2.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CD—obesity	2.37e-06	2.39e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NCOA1—obesity	2.36e-06	2.38e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARG—obesity	2.36e-06	2.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ESR1—obesity	2.36e-06	2.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	2.35e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SERPINE1—obesity	2.35e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CD—obesity	2.34e-06	2.36e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—STK11—obesity	2.33e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP19A1—obesity	2.33e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—obesity	2.33e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCB—obesity	2.33e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—F2—obesity	2.33e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—PIK3CA—obesity	2.32e-06	2.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TYK2—obesity	2.32e-06	2.34e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—INS—obesity	2.31e-06	2.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AKT1—obesity	2.31e-06	2.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—obesity	2.31e-06	2.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CG—obesity	2.31e-06	2.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RHOA—obesity	2.3e-06	2.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—BAD—obesity	2.3e-06	2.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—LPL—obesity	2.29e-06	2.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TYK2—obesity	2.28e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—obesity	2.28e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3R1—obesity	2.28e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOS3—obesity	2.28e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RHOA—obesity	2.26e-06	2.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MTOR—obesity	2.25e-06	2.27e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3CB—obesity	2.25e-06	2.27e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3R1—obesity	2.24e-06	2.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOS3—obesity	2.24e-06	2.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—obesity	2.24e-06	2.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CG—obesity	2.23e-06	2.25e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARG—obesity	2.23e-06	2.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—NOS3—obesity	2.21e-06	2.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3R1—obesity	2.21e-06	2.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS1—obesity	2.2e-06	2.22e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—obesity	2.19e-06	2.21e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—INS—obesity	2.18e-06	2.2e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CD36—obesity	2.18e-06	2.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—PIK3CA—obesity	2.17e-06	2.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—obesity	2.17e-06	2.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—COMT—obesity	2.16e-06	2.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CD—obesity	2.15e-06	2.17e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GNB3—obesity	2.13e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARGC1A—obesity	2.13e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	2.13e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—obesity	2.12e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—obesity	2.12e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—obesity	2.12e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—INS—obesity	2.11e-06	2.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK8—obesity	2.11e-06	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MTOR—obesity	2.1e-06	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3CB—obesity	2.1e-06	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AKT1—obesity	2.1e-06	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AKT1—obesity	2.09e-06	2.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GNAS—obesity	2.08e-06	2.1e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—obesity	2.07e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MTOR—obesity	2.07e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CB—obesity	2.07e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—obesity	2.07e-06	2.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—obesity	2.05e-06	2.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CB—obesity	2.04e-06	2.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1—obesity	2.04e-06	2.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT2—obesity	2.04e-06	2.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOB—obesity	2.04e-06	2.05e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—NOS3—obesity	2.03e-06	2.05e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3R1—obesity	2.03e-06	2.05e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CD—obesity	2.03e-06	2.05e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARA—obesity	2.03e-06	2.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—obesity	2.02e-06	2.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—obesity	2e-06	2.02e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AGT—obesity	1.96e-06	1.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.96e-06	1.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—obesity	1.95e-06	1.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AKT1—obesity	1.95e-06	1.97e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—LPL—obesity	1.94e-06	1.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.94e-06	1.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.94e-06	1.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—STAT3—obesity	1.92e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—obesity	1.92e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—obesity	1.92e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AKT1—obesity	1.92e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—NOS3—obesity	1.91e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3R1—obesity	1.91e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAV1—obesity	1.91e-06	1.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK8—obesity	1.9e-06	1.92e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOA1—obesity	1.9e-06	1.92e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—obesity	1.9e-06	1.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AKT1—obesity	1.9e-06	1.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—obesity	1.89e-06	1.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TYK2—obesity	1.88e-06	1.9e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CB—obesity	1.87e-06	1.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RHOA—obesity	1.87e-06	1.88e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—obesity	1.86e-06	1.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.85e-06	1.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOS3—obesity	1.85e-06	1.87e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CD36—obesity	1.85e-06	1.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—obesity	1.83e-06	1.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—obesity	1.8e-06	1.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MYC—obesity	1.79e-06	1.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—obesity	1.78e-06	1.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK8—obesity	1.78e-06	1.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AKT1—obesity	1.77e-06	1.79e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CB—obesity	1.77e-06	1.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.76e-06	1.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—obesity	1.75e-06	1.77e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—obesity	1.75e-06	1.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK8—obesity	1.75e-06	1.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AKT1—obesity	1.74e-06	1.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—STAT3—obesity	1.74e-06	1.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CG—obesity	1.74e-06	1.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARA—obesity	1.72e-06	1.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MTOR—obesity	1.71e-06	1.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.71e-06	1.72e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARG—obesity	1.67e-06	1.69e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AGT—obesity	1.66e-06	1.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—obesity	1.65e-06	1.67e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—INS—obesity	1.64e-06	1.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—obesity	1.63e-06	1.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—STAT3—obesity	1.62e-06	1.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MYC—obesity	1.61e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAV1—obesity	1.61e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—obesity	1.61e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOA1—obesity	1.61e-06	1.62e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—STAT3—obesity	1.6e-06	1.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.58e-06	1.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—obesity	1.56e-06	1.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.54e-06	1.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3CA—obesity	1.53e-06	1.55e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CD—obesity	1.53e-06	1.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3CA—obesity	1.52e-06	1.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MYC—obesity	1.51e-06	1.52e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—obesity	1.51e-06	1.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—obesity	1.5e-06	1.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MYC—obesity	1.48e-06	1.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—obesity	1.48e-06	1.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—obesity	1.48e-06	1.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CG—obesity	1.47e-06	1.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK8—obesity	1.44e-06	1.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3R1—obesity	1.44e-06	1.45e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NOS3—obesity	1.44e-06	1.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AKT1—obesity	1.44e-06	1.45e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARG—obesity	1.42e-06	1.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—obesity	1.4e-06	1.41e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—INS—obesity	1.39e-06	1.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3CA—obesity	1.37e-06	1.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—obesity	1.34e-06	1.36e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CB—obesity	1.33e-06	1.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—STAT3—obesity	1.32e-06	1.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—obesity	1.32e-06	1.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CD—obesity	1.29e-06	1.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3CA—obesity	1.28e-06	1.29e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—obesity	1.28e-06	1.29e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CA—obesity	1.26e-06	1.27e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AKT1—obesity	1.25e-06	1.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CA—obesity	1.24e-06	1.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT1—obesity	1.24e-06	1.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MYC—obesity	1.23e-06	1.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—obesity	1.22e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3R1—obesity	1.22e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NOS3—obesity	1.22e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—obesity	1.21e-06	1.22e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CA—obesity	1.14e-06	1.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—obesity	1.13e-06	1.14e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CB—obesity	1.13e-06	1.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT1—obesity	1.12e-06	1.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—obesity	1.12e-06	1.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—obesity	1.12e-06	1.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CA—obesity	1.08e-06	1.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT1—obesity	1.05e-06	1.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.04e-06	1.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT1—obesity	1.03e-06	1.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AKT1—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AKT1—obesity	9.33e-07	9.42e-06	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—obesity	9.21e-07	9.29e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AKT1—obesity	8.8e-07	8.88e-06	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT1—obesity	8.5e-07	8.57e-06	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CA—obesity	8.11e-07	8.18e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CA—obesity	6.87e-07	6.93e-06	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKT1—obesity	6.62e-07	6.68e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKT1—obesity	5.61e-07	5.66e-06	CbGpPWpGaD
